ARS Pharmaceuticals, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ARS Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • ARS Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $11K, a 45% decline year-over-year.
  • ARS Pharmaceuticals, Inc. annual Depreciation for 2023 was $73K, a 115% increase from 2022.
  • ARS Pharmaceuticals, Inc. annual Depreciation for 2022 was $34K, a 95.7% decline from 2021.
  • ARS Pharmaceuticals, Inc. annual Depreciation for 2021 was $783K, a 22.9% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $73K +$39K +115% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $34K -$749K -95.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $783K +$146K +22.9% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 $637K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.